Screener
MaxCyte MXCT Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: MaxCyte’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:32 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-095971
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $7,271 | $8,507 | $16,922 | $18,897 |
| Cost of goods sold | 1,675 | 1,519 | 3,244 | 3,016 |
| Gross profit | 5,596 | 6,988 | 13,678 | 15,881 |
| Operating expenses: | ||||
| Research and development | 4,253 | 6,269 | 8,110 | 12,172 |
| Sales and marketing | 3,364 | 5,786 | 6,792 | 11,484 |
| General and administrative | 7,258 | 8,080 | 13,224 | 16,606 |
| Depreciation and amortization | 953 | 1,080 | 1,969 | 2,141 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is MaxCyte's total revenue?
- MaxCyte (MXCT) reported total revenue of $7.27M in Q2 2026.
- How has MaxCyte's total revenue changed year-over-year?
- MaxCyte's total revenue decreased by 14.5% year-over-year, from $8.51M to $7.27M.
- What is the long-term trend for MaxCyte's total revenue?
- Over 4 years (2021 to 2025), MaxCyte's total revenue has grown at a -0.6% compound annual growth rate (CAGR), from $33.89M to $33.03M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about MaxCyte's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude